Hansen Medical to Present at the 29th Annual J.P. Morgan Healthcare Conference
04 1월 2011 - 6:01AM
Marketwired
Hansen Medical, Inc. (NASDAQ: HNSN), a global leader in flexible
robotics and the developer of robotic technology for accurate 3D
control of catheter movement, announced today that President and
CEO Bruce Barclay is scheduled to present at the 29th Annual J.P.
Morgan Healthcare Conference. The conference is being held January
10-13, 2011 at the Westin St. Francis Hotel in San Francisco,
California. Hansen Medical is scheduled to present on Thursday,
January 13, 2011 at 8:30 a.m. Pacific Time.
Hansen Medical will provide a live webcast of the audio
presentation. Interested parties may access the live webcast by
visiting the investor relations section of Hansen Medical's web
site at www.hansenmedical.com. A replay of the webcast will be
available at the site after the presentation.
About Hansen Medical, Inc. Hansen Medical,
Inc., based in Mountain View, California, develops products and
technology using robotics for the accurate positioning,
manipulation and control of catheters and catheter-based
technologies. The company's Sensei® system and its Sensei X Robotic
Catheter System were cleared by the U.S. Food and Drug
Administration for manipulation and control of certain mapping
catheters in electrophysiology (EP) procedures. This robotic
catheter system is compatible with fluoroscopy, ultrasound, 3D
surface map and patient electrocardiogram data. In the United
States, the Sensei System is not approved for use in guiding
ablation procedures; this use remains experimental. The U.S.
product labeling therefore provides that the safety and
effectiveness of the Sensei and Sensei X systems for use with
cardiac ablation catheters in the treatment of cardiac arrhythmias,
including atrial fibrillation (AF), have not been established
during EP procedures, such as guiding catheters in the treatment of
AF. In the European Union, the Sensei and the Sensei X systems are
cleared for use during EP procedures, such as guiding catheters in
the treatment of AF. Additional information can be found at
www.hansenmedical.com.
Investor Contacts: Peter Osborne Interim CFO Hansen Medical
650.404.5800 Matt Clawson Allen & Caron Inc. 949.474.4300 Email
Contact
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Hansen Medical, Inc. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Hansen Medical, Inc. News Articles